Classification:
Title:
Salcaprozate Sodium（SNAC）
CAS NO.：
203787-91-1
Summary:
GMP;US DMF
Description:
Tablet excipients are inactive substances added to tablet formulations to support the manufacturing process and ensure proper drug performance. They play essential roles such as improving powder flow, enhancing compressibility, aiding tablet binding, and controlling disintegration and dissolution rates. Common tablet excipients include diluents, binders, disintegrants, lubricants, and coatings. Although they have no therapeutic effect, tablet excipients are critical for ensuring dosage accuracy, physical stability, bioavailability, and patient acceptability.
Tablet excipients are inactive ingredients added to tablets to enhance stability, manufacturing performance, dissolution, and dosage consistency
Keywords:
Potassium decanoate
Sodium; 7-(2-hydroxy-benzoylamino)-heptanoate (SNAG)
Sodium; 6-(2-hydroxy-benzoylamino)-hexanoate (SNAJ)
Apixaban
Rivaroxaban
Ezetimibe
Similar related products
The products supplied by the company are only used for research and development. Except for the approval of the competent authority, it is strictly prohibited to be used in the production and sales of medicines, food and health products.
